Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Antimony potassium tartrate is a small molecule compound historically used as a schistosomicide and for the treatment of other parasitic diseases such as leishmaniasis and trypanosomiasis. It acts as a potent emetic and has been associated with significant toxicity, including lethal cardiac effects. The mechanism of action is not fully understood but may involve disruption of thiol proteins via binding to sulfhydryl groups. Its use in medicine has largely been discontinued due to severe side effects and the development of safer alternatives like praziquantel and pentavalent antimonials. Antimony potassium tartrate is now primarily used in industrial applications or as a chemical reagent[1][2][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on antimony potassium tartrate.